Trials / Completed
CompletedNCT01394406
Effect of Ketamine Added to Intravenous Patient-controlled Analgesia on Postoperative Pain, Nausea and Vomiting in Patients Undergoing Lumbar Spinal Surgery
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Yonsei University · Academic / Other
- Sex
- All
- Age
- 20 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Ketamine added to intravenous patient-controlled analgesia may be effective on prevention of postoperative nausea and vomiting by reducing opioid requirement after surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ketamine | ketamine 3 mg/kg mixed to intravenous patient controlled analgesia device (fentanyl 20 mcg/kg. total volume 180 ml, basal infusion 2 ml, bolus 2ml, lock-out 15 min) |
| DRUG | Saline | equal volume of normal saline mixed to intravenous patient controlled analgesia device |
Timeline
- Start date
- 2010-01-01
- Primary completion
- 2012-04-01
- Completion
- 2012-04-01
- First posted
- 2011-07-14
- Last updated
- 2014-03-05
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01394406. Inclusion in this directory is not an endorsement.